EMLUNGO
Live / Allowed — Notice of allowance issued (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99518752
- Mark type
- Word mark
- Filed
- 26 Nov 2025
- Published for opposition
- 28 Apr 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders
Owner
- Connect Biopharma Holdings Limited, San Diego, CA, KY
- Connect Biopharma Holdings Limited, San Diego, CA, KY
Prosecution history
- 23 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2026 — PUBLISHED FOR OPPOSITION
- 22 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2026 — ASSIGNED TO EXAMINER
- 26 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Nov 2025 — NEW APPLICATION ENTERED